[{"text": "Everybody in our society's life is touched by cancer --", "start": 15.33, "duration": 3.0}, {"text": "if not personally,", "start": 18.33, "duration": 2.0}, {"text": "then through a loved one, a family member,", "start": 20.33, "duration": 3.0}, {"text": "colleague, friend.", "start": 23.33, "duration": 2.0}, {"text": "And once our lives are touched by cancer,", "start": 25.33, "duration": 3.0}, {"text": "we quickly learn", "start": 28.33, "duration": 2.0}, {"text": "that there are basically", "start": 30.33, "duration": 2.0}, {"text": "three weapons, or three tools, that are available", "start": 32.33, "duration": 3.0}, {"text": "to fight the disease:", "start": 35.33, "duration": 3.0}, {"text": "surgery, radiation and chemotherapy.", "start": 38.33, "duration": 3.0}, {"text": "And once we get involved", "start": 41.33, "duration": 3.0}, {"text": "in the therapeutic decisions,", "start": 44.33, "duration": 3.0}, {"text": "again either personally", "start": 47.33, "duration": 2.0}, {"text": "or with our loved ones and family members,", "start": 49.33, "duration": 3.0}, {"text": "we also very quickly learn", "start": 52.33, "duration": 3.0}, {"text": "the benefits, the trade-offs and the limitations", "start": 55.33, "duration": 3.0}, {"text": "of these tools.", "start": 58.33, "duration": 2.0}, {"text": "I'm very thankful to Jay and to Mark", "start": 60.33, "duration": 2.0}, {"text": "and the TEDMED team", "start": 62.33, "duration": 2.0}, {"text": "for inviting me today", "start": 64.33, "duration": 2.0}, {"text": "to describe a fourth tool, a new tool,", "start": 66.33, "duration": 3.0}, {"text": "that we call Tumor Treating Fields.", "start": 69.33, "duration": 3.0}, {"text": "Tumor Treating Fields", "start": 72.33, "duration": 2.0}, {"text": "were invented by Dr. Yoram Palti,", "start": 74.33, "duration": 3.0}, {"text": "professor emeritus at the Technion in Israel.", "start": 77.33, "duration": 3.0}, {"text": "And they use low-intensity", "start": 80.33, "duration": 2.0}, {"text": "electric fields", "start": 82.33, "duration": 2.0}, {"text": "to fight cancer.", "start": 84.33, "duration": 2.0}, {"text": "To understand how Tumor Treating Fields work,", "start": 86.33, "duration": 3.0}, {"text": "we first need to understand", "start": 89.33, "duration": 2.0}, {"text": "what are electric fields.", "start": 91.33, "duration": 2.0}, {"text": "Let me first address", "start": 93.33, "duration": 3.0}, {"text": "a few popular misconceptions.", "start": 96.33, "duration": 3.0}, {"text": "First of all, electric fields", "start": 99.33, "duration": 2.0}, {"text": "are not an electric current", "start": 101.33, "duration": 2.0}, {"text": "that is coursing through the tissue.", "start": 103.33, "duration": 3.0}, {"text": "Electric fields", "start": 106.33, "duration": 2.0}, {"text": "are not ionizing radiation,", "start": 108.33, "duration": 2.0}, {"text": "like X-rays or proton beams,", "start": 110.33, "duration": 2.0}, {"text": "that bombard tissue", "start": 112.33, "duration": 2.0}, {"text": "to disrupt DNA.", "start": 114.33, "duration": 2.0}, {"text": "And electric fields", "start": 116.33, "duration": 2.0}, {"text": "are not magnetism.", "start": 118.33, "duration": 2.0}, {"text": "What electric fields are", "start": 120.33, "duration": 2.0}, {"text": "are a field of forces.", "start": 122.33, "duration": 3.0}, {"text": "And these forces", "start": 125.33, "duration": 2.0}, {"text": "act on, attract, bodies", "start": 127.33, "duration": 3.0}, {"text": "that have an electrical charge.", "start": 130.33, "duration": 3.0}, {"text": "The best way to visualize an electric field", "start": 133.33, "duration": 2.0}, {"text": "is to think of gravity.", "start": 135.33, "duration": 2.0}, {"text": "Gravity is also a field of forces", "start": 137.33, "duration": 3.0}, {"text": "that act on masses.", "start": 140.33, "duration": 2.0}, {"text": "We can all picture astronauts in space.", "start": 142.33, "duration": 3.0}, {"text": "They float freely in three dimensions", "start": 145.33, "duration": 2.0}, {"text": "without any forces acting on them.", "start": 147.33, "duration": 2.0}, {"text": "But as that space shuttle", "start": 149.33, "duration": 3.0}, {"text": "returns to Earth,", "start": 152.33, "duration": 2.0}, {"text": "and as the astronauts enter the Earth's gravitational field,", "start": 154.33, "duration": 3.0}, {"text": "they begin to see the effects of gravity.", "start": 157.33, "duration": 3.0}, {"text": "They begin to be attracted towards Earth.", "start": 160.33, "duration": 2.0}, {"text": "And as they land,", "start": 162.33, "duration": 2.0}, {"text": "they're fully aligned in the gravitational field.", "start": 164.33, "duration": 2.0}, {"text": "We're, of course, all stuck in the Earth's gravitational field right now.", "start": 166.33, "duration": 3.0}, {"text": "That's why you're all in your chairs.", "start": 169.33, "duration": 3.0}, {"text": "And that's why we have to use our muscle energy", "start": 172.33, "duration": 2.0}, {"text": "to stand up, to walk around", "start": 174.33, "duration": 2.0}, {"text": "and to lift things.", "start": 176.33, "duration": 3.0}, {"text": "In cancer,", "start": 179.33, "duration": 2.0}, {"text": "cells rapidly divide", "start": 181.33, "duration": 2.0}, {"text": "and lead to uncontrolled tumor growth.", "start": 183.33, "duration": 3.0}, {"text": "We can think of a cell", "start": 186.33, "duration": 3.0}, {"text": "from an electrical perspective", "start": 189.33, "duration": 2.0}, {"text": "as if it's a mini space station.", "start": 191.33, "duration": 3.0}, {"text": "And in that space station", "start": 194.33, "duration": 2.0}, {"text": "we have the genetic material, the chromosomes,", "start": 196.33, "duration": 3.0}, {"text": "within a nucleus.", "start": 199.33, "duration": 2.0}, {"text": "And out in the cytoplasmic soup", "start": 201.33, "duration": 2.0}, {"text": "we have special proteins", "start": 203.33, "duration": 2.0}, {"text": "that are required for cell division", "start": 205.33, "duration": 2.0}, {"text": "that float freely in this soup", "start": 207.33, "duration": 2.0}, {"text": "in three dimensions.", "start": 209.33, "duration": 2.0}, {"text": "Importantly, those special proteins", "start": 211.33, "duration": 3.0}, {"text": "are among the most highly charged objects", "start": 214.33, "duration": 3.0}, {"text": "in our body.", "start": 217.33, "duration": 2.0}, {"text": "As cell division begins", "start": 219.33, "duration": 2.0}, {"text": "the nucleus disintegrates,", "start": 221.33, "duration": 2.0}, {"text": "the chromosomes line up", "start": 223.33, "duration": 2.0}, {"text": "in the middle of the cell", "start": 225.33, "duration": 2.0}, {"text": "and those special proteins", "start": 227.33, "duration": 2.0}, {"text": "undergo a three-dimensional sequence", "start": 229.33, "duration": 4.0}, {"text": "whereby they attach", "start": 233.33, "duration": 2.0}, {"text": "and they literally click into place end-on-end", "start": 235.33, "duration": 3.0}, {"text": "to form chains.", "start": 238.33, "duration": 2.0}, {"text": "These chains", "start": 240.33, "duration": 2.0}, {"text": "then progress and attach", "start": 242.33, "duration": 2.0}, {"text": "to the genetic material", "start": 244.33, "duration": 3.0}, {"text": "and pull the genetic material", "start": 247.33, "duration": 2.0}, {"text": "from one cell into two cells.", "start": 249.33, "duration": 2.0}, {"text": "And this is exactly how", "start": 251.33, "duration": 2.0}, {"text": "one cancer cell becomes two cancer cells,", "start": 253.33, "duration": 2.0}, {"text": "two cancer cells become four cancer cells,", "start": 255.33, "duration": 2.0}, {"text": "and we have ultimately", "start": 257.33, "duration": 2.0}, {"text": "uncontrolled tumor growth.", "start": 259.33, "duration": 3.0}, {"text": "Tumor Treating Fields", "start": 262.33, "duration": 3.0}, {"text": "use externally placed transducers", "start": 265.33, "duration": 4.0}, {"text": "attached to a field generator", "start": 269.33, "duration": 3.0}, {"text": "to create an artificial electric field", "start": 272.33, "duration": 4.0}, {"text": "on that space station.", "start": 276.33, "duration": 3.0}, {"text": "And when that cellular space station", "start": 279.33, "duration": 3.0}, {"text": "is within the electric field,", "start": 282.33, "duration": 2.0}, {"text": "it acts on those highly charged proteins", "start": 284.33, "duration": 4.0}, {"text": "and aligns them.", "start": 288.33, "duration": 2.0}, {"text": "And it prevents them from forming those chains,", "start": 290.33, "duration": 3.0}, {"text": "those mitotic spindles,", "start": 293.33, "duration": 2.0}, {"text": "that are necessary to pull the genetic material", "start": 295.33, "duration": 3.0}, {"text": "into the daughter cells.", "start": 298.33, "duration": 2.0}, {"text": "What we see is that the cells will attempt to divide", "start": 300.33, "duration": 3.0}, {"text": "for several hours.", "start": 303.33, "duration": 2.0}, {"text": "And they will either enter into", "start": 305.33, "duration": 3.0}, {"text": "this so-called cellular suicide,", "start": 308.33, "duration": 2.0}, {"text": "programmed cell death,", "start": 310.33, "duration": 2.0}, {"text": "or they will form unhealthy daughter cells", "start": 312.33, "duration": 3.0}, {"text": "and enter into apoptosis", "start": 315.33, "duration": 3.0}, {"text": "once they have divided.", "start": 318.33, "duration": 2.0}, {"text": "And we can observe this.", "start": 320.33, "duration": 2.0}, {"text": "What I'm going to show you next", "start": 322.33, "duration": 2.0}, {"text": "are two in vitro experiments.", "start": 324.33, "duration": 2.0}, {"text": "This is cultures, identical cultures,", "start": 326.33, "duration": 3.0}, {"text": "of cervical cancer cells.", "start": 329.33, "duration": 2.0}, {"text": "And we've stained these cultures", "start": 331.33, "duration": 2.0}, {"text": "with a green florescent dye", "start": 333.33, "duration": 2.0}, {"text": "so that we can look at these proteins", "start": 335.33, "duration": 3.0}, {"text": "that form these chains.", "start": 338.33, "duration": 2.0}, {"text": "The first clip shows", "start": 340.33, "duration": 2.0}, {"text": "a normal cell division", "start": 342.33, "duration": 3.0}, {"text": "without the Tumor Treating Fields.", "start": 345.33, "duration": 3.0}, {"text": "What we see", "start": 348.33, "duration": 2.0}, {"text": "are, first of all, a very active culture,", "start": 350.33, "duration": 2.0}, {"text": "a lot of divisions,", "start": 352.33, "duration": 2.0}, {"text": "and then very clear nuclei", "start": 354.33, "duration": 2.0}, {"text": "once the cells have separated.", "start": 356.33, "duration": 2.0}, {"text": "And we can see them dividing throughout.", "start": 358.33, "duration": 2.0}, {"text": "When we apply the fields --", "start": 360.33, "duration": 2.0}, {"text": "again, in the identical time-scale", "start": 362.33, "duration": 2.0}, {"text": "to the identical culture --", "start": 364.33, "duration": 2.0}, {"text": "you're going to see something different.", "start": 366.33, "duration": 2.0}, {"text": "The cells round up for division,", "start": 368.33, "duration": 2.0}, {"text": "but they're very static in that position.", "start": 370.33, "duration": 3.0}, {"text": "We'll see two cells", "start": 373.33, "duration": 2.0}, {"text": "in the upper part of the screen", "start": 375.33, "duration": 5.0}, {"text": "attempting to divide.", "start": 380.33, "duration": 2.0}, {"text": "The one within the circle manages.", "start": 382.33, "duration": 2.0}, {"text": "But see how much of the protein", "start": 384.33, "duration": 2.0}, {"text": "is still throughout the nucleus,", "start": 386.33, "duration": 2.0}, {"text": "even in the dividing cell.", "start": 388.33, "duration": 2.0}, {"text": "The one up there can't divide at all.", "start": 390.33, "duration": 2.0}, {"text": "And then this bubbling, this membrane bubbling,", "start": 392.33, "duration": 3.0}, {"text": "is the hallmark", "start": 395.33, "duration": 2.0}, {"text": "of apoptosis in this cell.", "start": 397.33, "duration": 3.0}, {"text": "Formation of healthy mitotic spindles", "start": 400.33, "duration": 4.0}, {"text": "is necessary for division", "start": 404.33, "duration": 3.0}, {"text": "in all cell types.", "start": 407.33, "duration": 2.0}, {"text": "We've applied Tumor Treating Fields", "start": 409.33, "duration": 2.0}, {"text": "to over 20 different cancers in the lab,", "start": 411.33, "duration": 3.0}, {"text": "and we see this effect", "start": 414.33, "duration": 2.0}, {"text": "in all of them.", "start": 416.33, "duration": 3.0}, {"text": "Now importantly,", "start": 419.33, "duration": 2.0}, {"text": "these Tumor Treating Fields have no effect", "start": 421.33, "duration": 3.0}, {"text": "on normal undividing cells.", "start": 424.33, "duration": 2.0}, {"text": "10 years ago,", "start": 426.33, "duration": 2.0}, {"text": "Dr. Palti founded a company called Novocure", "start": 428.33, "duration": 3.0}, {"text": "to develop his discovery", "start": 431.33, "duration": 3.0}, {"text": "into a practical therapy for patients.", "start": 434.33, "duration": 3.0}, {"text": "In that time, Novocure's developed two systems --", "start": 437.33, "duration": 4.0}, {"text": "one system for cancers in the head", "start": 441.33, "duration": 3.0}, {"text": "and another system for cancers in the trunk of the body.", "start": 444.33, "duration": 3.0}, {"text": "The first cancer that we have focused on", "start": 447.33, "duration": 3.0}, {"text": "is the deadly brain cancer, GBM.", "start": 450.33, "duration": 3.0}, {"text": "GBM affects about 10,000 people", "start": 453.33, "duration": 3.0}, {"text": "in the U.S. each year.", "start": 456.33, "duration": 3.0}, {"text": "It's a death sentence.", "start": 459.33, "duration": 2.0}, {"text": "The expected five year survival", "start": 461.33, "duration": 2.0}, {"text": "is less than five percent.", "start": 463.33, "duration": 2.0}, {"text": "And the typical patient", "start": 465.33, "duration": 2.0}, {"text": "with optimal therapy", "start": 467.33, "duration": 2.0}, {"text": "survives just a little over a year,", "start": 469.33, "duration": 3.0}, {"text": "and only about seven months", "start": 472.33, "duration": 2.0}, {"text": "from the time that the cancer is first treated", "start": 474.33, "duration": 3.0}, {"text": "and then comes back and starts growing again.", "start": 477.33, "duration": 3.0}, {"text": "Novocure conducted", "start": 482.33, "duration": 2.0}, {"text": "its first phase three randomized trial", "start": 484.33, "duration": 2.0}, {"text": "in patients with recurrent GBM.", "start": 486.33, "duration": 2.0}, {"text": "So these are patients", "start": 488.33, "duration": 2.0}, {"text": "who had received surgery,", "start": 490.33, "duration": 4.0}, {"text": "high dose radiation to the head", "start": 494.33, "duration": 2.0}, {"text": "and first-line chemotherapy,", "start": 496.33, "duration": 2.0}, {"text": "and that had failed and their tumors had grown back.", "start": 498.33, "duration": 3.0}, {"text": "We divided the patients into two groups.", "start": 501.33, "duration": 3.0}, {"text": "The first group received second-line chemotherapy,", "start": 504.33, "duration": 3.0}, {"text": "which is expected to double the life expectancy,", "start": 507.33, "duration": 3.0}, {"text": "versus no treatment at all.", "start": 510.33, "duration": 2.0}, {"text": "And then the second group", "start": 512.33, "duration": 2.0}, {"text": "received only Tumor Treating Field therapy.", "start": 514.33, "duration": 3.0}, {"text": "What we saw in that trial", "start": 517.33, "duration": 2.0}, {"text": "is that that the life expectancies of both groups --", "start": 519.33, "duration": 3.0}, {"text": "so the chemotherapy treated group", "start": 522.33, "duration": 2.0}, {"text": "and the Tumor Treating Field group --", "start": 524.33, "duration": 2.0}, {"text": "was the same.", "start": 526.33, "duration": 2.0}, {"text": "But importantly,", "start": 528.33, "duration": 2.0}, {"text": "the Tumor Treating Field group", "start": 530.33, "duration": 3.0}, {"text": "suffered none of the side effects", "start": 533.33, "duration": 3.0}, {"text": "typical of chemotherapy patients.", "start": 536.33, "duration": 3.0}, {"text": "They had no pain,", "start": 539.33, "duration": 2.0}, {"text": "suffered none of the infections.", "start": 541.33, "duration": 3.0}, {"text": "They had no nausea, diarrhea,", "start": 544.33, "duration": 3.0}, {"text": "constipation, fatigue", "start": 547.33, "duration": 3.0}, {"text": "that would be expected.", "start": 550.33, "duration": 2.0}, {"text": "Based on this trial,", "start": 552.33, "duration": 2.0}, {"text": "in April of this year,", "start": 554.33, "duration": 2.0}, {"text": "the FDA approved Tumor Treating Fields", "start": 556.33, "duration": 3.0}, {"text": "for the treatment of patients", "start": 559.33, "duration": 2.0}, {"text": "with recurrent GBM.", "start": 561.33, "duration": 3.0}, {"text": "Importantly, it was the first time ever", "start": 564.33, "duration": 3.0}, {"text": "that the FDA included", "start": 567.33, "duration": 2.0}, {"text": "in their approval of an oncology treatment", "start": 569.33, "duration": 3.0}, {"text": "a quality of life claim.", "start": 572.33, "duration": 2.0}, {"text": "So I'm going to show you now", "start": 576.33, "duration": 3.0}, {"text": "one of the patients", "start": 579.33, "duration": 2.0}, {"text": "from this trial.", "start": 581.33, "duration": 3.0}, {"text": "Robert Dill-Bundi", "start": 584.33, "duration": 2.0}, {"text": "is a famous Swiss cycling champion.", "start": 586.33, "duration": 2.0}, {"text": "He won the gold medal in Moscow", "start": 588.33, "duration": 2.0}, {"text": "in the 4,000 meter pursuit.", "start": 590.33, "duration": 3.0}, {"text": "And five years ago,", "start": 593.33, "duration": 3.0}, {"text": "Robert was diagnosed with GBM.", "start": 596.33, "duration": 3.0}, {"text": "He received the standard treatments.", "start": 599.33, "duration": 2.0}, {"text": "He received surgery.", "start": 601.33, "duration": 3.0}, {"text": "He received high dose radiation to the head.", "start": 604.33, "duration": 3.0}, {"text": "And he received first-line chemotherapy.", "start": 607.33, "duration": 3.0}, {"text": "A year after this treatment --", "start": 610.33, "duration": 2.0}, {"text": "in fact, this is his baseline MRI.", "start": 612.33, "duration": 3.0}, {"text": "You can see that the black regions", "start": 615.33, "duration": 3.0}, {"text": "in the upper right quadrant", "start": 618.33, "duration": 2.0}, {"text": "are the areas where he had surgery.", "start": 620.33, "duration": 2.0}, {"text": "And a year after that treatment,", "start": 622.33, "duration": 2.0}, {"text": "his tumor grew back with a vengeance.", "start": 624.33, "duration": 3.0}, {"text": "That cloudy white mass that you see", "start": 627.33, "duration": 3.0}, {"text": "is the recurrence of the tumor.", "start": 630.33, "duration": 3.0}, {"text": "At this point, he was told by his doctors", "start": 633.33, "duration": 3.0}, {"text": "that he had about 3 months to live.", "start": 636.33, "duration": 3.0}, {"text": "He entered our trial.", "start": 639.33, "duration": 2.0}, {"text": "And here we can see him getting the therapy.", "start": 641.33, "duration": 3.0}, {"text": "First of all, these electrodes are noninvasive.", "start": 644.33, "duration": 3.0}, {"text": "They're attached to the skin", "start": 647.33, "duration": 2.0}, {"text": "in the area of the tumor.", "start": 649.33, "duration": 2.0}, {"text": "Here you can see", "start": 651.33, "duration": 2.0}, {"text": "that a technician is placing them on there much like bandages.", "start": 653.33, "duration": 3.0}, {"text": "The patients learn to do this themselves", "start": 656.33, "duration": 3.0}, {"text": "And then the patients", "start": 659.33, "duration": 3.0}, {"text": "can undergo all the activities of their daily life.", "start": 662.33, "duration": 3.0}, {"text": "There's none of the tiredness.", "start": 665.33, "duration": 2.0}, {"text": "There's none of what is called the \"chemo head.\"", "start": 667.33, "duration": 3.0}, {"text": "There's no sensation.", "start": 670.33, "duration": 2.0}, {"text": "It doesn't interfere", "start": 672.33, "duration": 2.0}, {"text": "with computers or electrical equipment.", "start": 674.33, "duration": 3.0}, {"text": "And the therapy is delivered continuously", "start": 677.33, "duration": 2.0}, {"text": "at home,", "start": 679.33, "duration": 2.0}, {"text": "without having to go into the hospital", "start": 681.33, "duration": 2.0}, {"text": "either periodically or continually.", "start": 683.33, "duration": 3.0}, {"text": "These are Robert's MRIs,", "start": 686.33, "duration": 3.0}, {"text": "again, under only TTField treatment.", "start": 689.33, "duration": 3.0}, {"text": "This is a therapy that takes time to work.", "start": 692.33, "duration": 3.0}, {"text": "It's a medical device;", "start": 695.33, "duration": 2.0}, {"text": "it works when it's on.", "start": 697.33, "duration": 2.0}, {"text": "But what we can see is, by month six,", "start": 699.33, "duration": 2.0}, {"text": "the tumor has responded", "start": 701.33, "duration": 3.0}, {"text": "and it's begun to melt away.", "start": 704.33, "duration": 3.0}, {"text": "It's still there.", "start": 707.33, "duration": 2.0}, {"text": "By month 12,", "start": 709.33, "duration": 2.0}, {"text": "we could argue whether", "start": 711.33, "duration": 2.0}, {"text": "there's a little bit of material around the edges,", "start": 713.33, "duration": 2.0}, {"text": "but it's essentially completely gone.", "start": 715.33, "duration": 3.0}, {"text": "It's now five years", "start": 718.33, "duration": 2.0}, {"text": "since Robert's diagnosis,", "start": 720.33, "duration": 2.0}, {"text": "and he's alive,", "start": 722.33, "duration": 3.0}, {"text": "but importantly, he's healthy", "start": 725.33, "duration": 2.0}, {"text": "and he's at work.", "start": 727.33, "duration": 2.0}, {"text": "I'm going to let him, in this very short clip,", "start": 729.33, "duration": 2.0}, {"text": "describe his impressions of the therapy", "start": 731.33, "duration": 2.0}, {"text": "in his own words.", "start": 733.33, "duration": 2.0}, {"text": "(Video) Robert Dill-Bundi: My quality of life,", "start": 735.33, "duration": 2.0}, {"text": "I rate what I have today", "start": 737.33, "duration": 2.0}, {"text": "a bit different than what most people would assume.", "start": 739.33, "duration": 4.0}, {"text": "I am the happiest, the happiest person in the world.", "start": 743.33, "duration": 5.0}, {"text": "And every single morning I appreciate life.", "start": 748.33, "duration": 4.0}, {"text": "Every night I fall asleep very well,", "start": 752.33, "duration": 3.0}, {"text": "and I am, I repeat,", "start": 755.33, "duration": 3.0}, {"text": "the happiest man in the world,", "start": 758.33, "duration": 2.0}, {"text": "and I'm thankful I am alive.", "start": 760.33, "duration": 3.0}, {"text": "BD: Novocure's also working on lung cancer", "start": 765.33, "duration": 3.0}, {"text": "as the second target.", "start": 768.33, "duration": 2.0}, {"text": "We've run a phase two trial", "start": 770.33, "duration": 2.0}, {"text": "in Switzerland", "start": 772.33, "duration": 2.0}, {"text": "on, again, recurrent patients --", "start": 774.33, "duration": 2.0}, {"text": "patients who have received standard therapy", "start": 776.33, "duration": 3.0}, {"text": "and whose cancer has come back.", "start": 779.33, "duration": 3.0}, {"text": "I'm going to show you another clip", "start": 782.33, "duration": 2.0}, {"text": "of a woman named Lydia.", "start": 784.33, "duration": 2.0}, {"text": "Lydia's a 66 year-old farmer", "start": 786.33, "duration": 2.0}, {"text": "in Switzerland.", "start": 788.33, "duration": 2.0}, {"text": "She was diagnosed with lung cancer", "start": 790.33, "duration": 2.0}, {"text": "five years ago.", "start": 792.33, "duration": 2.0}, {"text": "She underwent four different regimes of chemotherapy", "start": 794.33, "duration": 3.0}, {"text": "over two years,", "start": 797.33, "duration": 2.0}, {"text": "none of which had an effect.", "start": 799.33, "duration": 2.0}, {"text": "Her cancer continued to grow.", "start": 801.33, "duration": 2.0}, {"text": "Three years ago,", "start": 803.33, "duration": 2.0}, {"text": "she entered the Novocure lung cancer trial.", "start": 805.33, "duration": 4.0}, {"text": "You can see, in her case,", "start": 809.33, "duration": 2.0}, {"text": "she's wearing her transducer arrays,", "start": 811.33, "duration": 2.0}, {"text": "one of the front of her chest, one on the back,", "start": 813.33, "duration": 3.0}, {"text": "and then the second pair side-to-side over the liver.", "start": 816.33, "duration": 3.0}, {"text": "You can see the Tumor Treating Field field generator,", "start": 819.33, "duration": 3.0}, {"text": "but importantly you can also see that she is living her life.", "start": 822.33, "duration": 3.0}, {"text": "She is managing her farm.", "start": 825.33, "duration": 2.0}, {"text": "She's interacting with her kids and her grand kids.", "start": 827.33, "duration": 3.0}, {"text": "And when we talked to her,", "start": 830.33, "duration": 3.0}, {"text": "she said that when she was undergoing chemotherapy,", "start": 833.33, "duration": 2.0}, {"text": "she had to go to the hospital every month for her infusions.", "start": 835.33, "duration": 3.0}, {"text": "Her whole family suffered", "start": 838.33, "duration": 2.0}, {"text": "as her side effect profile came and went.", "start": 840.33, "duration": 2.0}, {"text": "Now she can run", "start": 842.33, "duration": 2.0}, {"text": "all of the activities of her farm.", "start": 844.33, "duration": 3.0}, {"text": "It's only the beginning.", "start": 847.33, "duration": 2.0}, {"text": "(Applause)", "start": 849.33, "duration": 7.0}, {"text": "In the lab, we've observed tremendous synergies", "start": 856.33, "duration": 4.0}, {"text": "between chemotherapy and Tumor Treating Fields.", "start": 860.33, "duration": 3.0}, {"text": "There's research underway now at Harvard Medical School", "start": 863.33, "duration": 3.0}, {"text": "to pick the optimum pairs", "start": 866.33, "duration": 2.0}, {"text": "to maximize that benefit.", "start": 868.33, "duration": 2.0}, {"text": "We also believe that Tumor Treating Fields will work with radiation", "start": 870.33, "duration": 3.0}, {"text": "and interrupt the self-repair mechanisms that we have.", "start": 873.33, "duration": 4.0}, {"text": "There's now a new research project underway", "start": 877.33, "duration": 2.0}, {"text": "at the Karolinska in Sweden", "start": 879.33, "duration": 2.0}, {"text": "to prove that hypothesis.", "start": 881.33, "duration": 2.0}, {"text": "We have more trials planned", "start": 883.33, "duration": 2.0}, {"text": "for lung cancer,", "start": 885.33, "duration": 2.0}, {"text": "pancreatic cancer, ovarian cancer", "start": 887.33, "duration": 2.0}, {"text": "and breast cancer.", "start": 889.33, "duration": 2.0}, {"text": "And I firmly believe", "start": 891.33, "duration": 2.0}, {"text": "that in the next 10 years", "start": 893.33, "duration": 2.0}, {"text": "Tumor Treating Fields", "start": 895.33, "duration": 2.0}, {"text": "will be a weapon available to doctors and patients", "start": 897.33, "duration": 3.0}, {"text": "for all of these most-difficult-to-treat solid tumors.", "start": 900.33, "duration": 5.0}, {"text": "I'm also very hopeful", "start": 906.33, "duration": 2.0}, {"text": "that in the next decades,", "start": 908.33, "duration": 2.0}, {"text": "we will make big strides", "start": 910.33, "duration": 2.0}, {"text": "on reducing that death rate", "start": 912.33, "duration": 3.0}, {"text": "that has been so challenging in this disease.", "start": 915.33, "duration": 3.0}, {"text": "Thank you.", "start": 918.33, "duration": 2.0}, {"text": "(Applause)", "start": 920.33, "duration": 9.0}]